2017 FDA Peptide Harvest
2017 was an excellent year in terms of new drugs (chemical entities and biologics) approved by the FDA, with a total of 46. In turn, one of the highlights was the number of peptides (six) included in this list. Here, the six peptides are analyzed in terms of chemical structure, synthetic strategy us...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2018-05-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | http://www.mdpi.com/1424-8247/11/2/42 |
id |
doaj-510cb20f4fcc4cbcaeecfb67a3cee263 |
---|---|
record_format |
Article |
spelling |
doaj-510cb20f4fcc4cbcaeecfb67a3cee2632020-11-25T01:59:44ZengMDPI AGPharmaceuticals1424-82472018-05-011124210.3390/ph11020042ph110200422017 FDA Peptide HarvestOthman Al Musaimi0Danah Al Shaer1Beatriz G. de la Torre2Fernando Albericio3College of Health Sciences, University of KwaZulu-Natal, Durban 4000, South AfricaCollege of Health Sciences, University of KwaZulu-Natal, Durban 4000, South AfricaKRISP, College of Health Sciences, University of KwaZulu-Natal, Durban 4001, South AfricaSchool of Chemistry, University of KwaZulu-Natal, Durban 4001, South Africa2017 was an excellent year in terms of new drugs (chemical entities and biologics) approved by the FDA, with a total of 46. In turn, one of the highlights was the number of peptides (six) included in this list. Here, the six peptides are analyzed in terms of chemical structure, synthetic strategy used for their production, source, therapeutic use, and mode of action.http://www.mdpi.com/1424-8247/11/2/42pharmaceutical marketdrugsdrug discoverysolid-phase peptide synthesis |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Othman Al Musaimi Danah Al Shaer Beatriz G. de la Torre Fernando Albericio |
spellingShingle |
Othman Al Musaimi Danah Al Shaer Beatriz G. de la Torre Fernando Albericio 2017 FDA Peptide Harvest Pharmaceuticals pharmaceutical market drugs drug discovery solid-phase peptide synthesis |
author_facet |
Othman Al Musaimi Danah Al Shaer Beatriz G. de la Torre Fernando Albericio |
author_sort |
Othman Al Musaimi |
title |
2017 FDA Peptide Harvest |
title_short |
2017 FDA Peptide Harvest |
title_full |
2017 FDA Peptide Harvest |
title_fullStr |
2017 FDA Peptide Harvest |
title_full_unstemmed |
2017 FDA Peptide Harvest |
title_sort |
2017 fda peptide harvest |
publisher |
MDPI AG |
series |
Pharmaceuticals |
issn |
1424-8247 |
publishDate |
2018-05-01 |
description |
2017 was an excellent year in terms of new drugs (chemical entities and biologics) approved by the FDA, with a total of 46. In turn, one of the highlights was the number of peptides (six) included in this list. Here, the six peptides are analyzed in terms of chemical structure, synthetic strategy used for their production, source, therapeutic use, and mode of action. |
topic |
pharmaceutical market drugs drug discovery solid-phase peptide synthesis |
url |
http://www.mdpi.com/1424-8247/11/2/42 |
work_keys_str_mv |
AT othmanalmusaimi 2017fdapeptideharvest AT danahalshaer 2017fdapeptideharvest AT beatrizgdelatorre 2017fdapeptideharvest AT fernandoalbericio 2017fdapeptideharvest |
_version_ |
1724962815677038592 |